Related Experiment Video
Updated: Aug 8, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous
R E Roller1, S Janisch, V Carroll
1Department of Vascular Biology and Thrombosis Research, University of Vienna, Austria.
Insights
Peripheral arterial occlusive disease (PAOD) patients show impaired fibrinolysis after angioplasty, with higher PAI-1 activity linked to restenosis. This suggests fibrinolysis plays a role in vascular repair after PTA.
Area of Science:
- Vascular Biology
- Hemostasis and Thrombosis
- Interventional Cardiology
Background:
- Peripheral arterial occlusive disease (PAOD) is characterized by impaired blood flow in the limbs.
- Percutaneous transluminal angioplasty (PTA) is a common intervention for PAOD.
- Fibrinolysis, the breakdown of blood clots, plays a crucial role in vascular health and repair.
Purpose of the Study:
- To investigate fibrinolytic parameters in PAOD patients before and after PTA.
- To compare fibrinolytic profiles between PAOD patients and healthy controls.
- To identify potential markers for restenosis following PTA.
Main Methods:
- Assessed fibrinolytic parameters including t-PA antigen, PAI-1 antigen and activity, PCI, and fibrinogen levels.
- Measured these parameters in 33 PAOD patients pre-PTA and at 6, 24, and 48 hours post-PTA.
- Compared patient data with 35 age- and gender-matched healthy controls.
Main Results:
- PAOD patients exhibited higher baseline levels of t-PA antigen, PAI-1 antigen and activity, PCI, and fibrinogen compared to controls.
- Fibrinolytic parameters and fibrinogen levels increased post-PTA, peaking at 24 and 48 hours.
- Restenosis occurred in 42% of patients; those with restenosis had significantly higher PAI-1 activity 24 and 48 hours post-PTA.
Conclusions:
- PAOD patients have altered fibrinolytic profiles, with elevated PAI-1 levels.
- Impaired fibrinolysis post-PTA may indicate a disturbed vascular repair process.
- Elevated PAI-1 activity after PTA could serve as a marker for late restenosis.
Abstract:
We have investigated fibrinolytic parameters in 33 patients with peripheral arterial occlusive disease (PAOD) before and 6, 24, and 48 hours after percutaneous transluminal angioplasty (PTA) as well as in 35 gender-matched healthy controls, whose mean age was not significantly different from the mean age of the patients. PAOD patients had significantly higher plasma levels of t-PA antigen (12.0+/-4.9 vs. 9.2+/-5.5 ng/ml), PAI-1 antigen (34.8+/-22.1 vs. 27.2+/-23.6 ng/ml), PAI-1 activity (10.0+/-6.5 vs. 8.0+/-8.0 U/ml), PCI (188.2+/-55.6 vs. 134.1+/-75.5% as compared with normal human plasma), and fibrinogen (420.2+/-92.6 vs. 261.9+/-32.7 mg/dl) as compared with controls. After angioplasty, fibrinolytic parameters and fibrinogen levels increased, reaching higher than preintervention levels 24 and 48 hours after the intervention. Six months after initially successful PTA, restenosis was demonstrated in 14 out of 33 patients (42%). Patients with late restenosis had significantly higher levels of PAI-1 activity 24 and 48 hours after PTA, as compared with patients with late patency (24 hours: 16.1+/-8.0 vs. 10.0+/-7.4; 48 hours: 16.5+/-7.9 vs. 12.0+/-7.0; p<0.05 for both time points). The results suggest that impaired fibrinolysis early after PTA might be a cause or marker of a disturbed repair process of vascular injury, leading to restenosis.
More Related Videos
Related Concept Videos
Clot Retraction and Fibrinolysis
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care

